Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Mycosis Fungoides Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Small Molecules 1.4.3 Biologics 1.5 Market by Application 1.5.1 Global Mycosis Fungoides Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Mycosis Fungoides Therapeutics Market Perspective (2015-2026) 2.2 Mycosis Fungoides Therapeutics Growth Trends by Regions 2.2.1 Mycosis Fungoides Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Mycosis Fungoides Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Mycosis Fungoides Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Mycosis Fungoides Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Mycosis Fungoides Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Mycosis Fungoides Therapeutics Players by Market Size 3.1.1 Global Top Mycosis Fungoides Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Mycosis Fungoides Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Mycosis Fungoides Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Mycosis Fungoides Therapeutics Market Concentration Ratio 3.2.1 Global Mycosis Fungoides Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Mycosis Fungoides Therapeutics Revenue in 2019 3.3 Mycosis Fungoides Therapeutics Key Players Head office and Area Served 3.4 Key Players Mycosis Fungoides Therapeutics Product Solution and Service 3.5 Date of Enter into Mycosis Fungoides Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Mycosis Fungoides Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Mycosis Fungoides Therapeutics Forecasted Market Size by Type (2021-2026) 5 Mycosis Fungoides Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) 5.2 Global Mycosis Fungoides Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Mycosis Fungoides Therapeutics Market Size (2015-2020) 6.2 Mycosis Fungoides Therapeutics Key Players in North America (2019-2020) 6.3 North America Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) 6.4 North America Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Mycosis Fungoides Therapeutics Market Size (2015-2020) 7.2 Mycosis Fungoides Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) 7.4 Europe Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Mycosis Fungoides Therapeutics Market Size (2015-2020) 8.2 Mycosis Fungoides Therapeutics Key Players in China (2019-2020) 8.3 China Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) 8.4 China Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Mycosis Fungoides Therapeutics Market Size (2015-2020) 9.2 Mycosis Fungoides Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) 9.4 Japan Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Mycosis Fungoides Therapeutics Market Size (2015-2020) 10.2 Mycosis Fungoides Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Mycosis Fungoides Therapeutics Market Size (2015-2020) 11.2 Mycosis Fungoides Therapeutics Key Players in India (2019-2020) 11.3 India Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) 11.4 India Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Mycosis Fungoides Therapeutics Market Size (2015-2020) 12.2 Mycosis Fungoides Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Azurity Pharmaceuticals Inc. 13.1.1 Azurity Pharmaceuticals Inc. Company Details 13.1.2 Azurity Pharmaceuticals Inc. Business Overview and Its Total Revenue 13.1.3 Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Introduction 13.1.4 Azurity Pharmaceuticals Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020)) 13.1.5 Azurity Pharmaceuticals Inc. Recent Development 13.2 Celgene Corp. 13.2.1 Celgene Corp. Company Details 13.2.2 Celgene Corp. Business Overview and Its Total Revenue 13.2.3 Celgene Corp. Mycosis Fungoides Therapeutics Introduction 13.2.4 Celgene Corp. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) 13.2.5 Celgene Corp. Recent Development 13.3 Eisai Co. Ltd. 13.3.1 Eisai Co. Ltd. Company Details 13.3.2 Eisai Co. Ltd. Business Overview and Its Total Revenue 13.3.3 Eisai Co. Ltd. Mycosis Fungoides Therapeutics Introduction 13.3.4 Eisai Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) 13.3.5 Eisai Co. Ltd. Recent Development 13.4 Helsinn Healthcare SA 13.4.1 Helsinn Healthcare SA Company Details 13.4.2 Helsinn Healthcare SA Business Overview and Its Total Revenue 13.4.3 Helsinn Healthcare SA Mycosis Fungoides Therapeutics Introduction 13.4.4 Helsinn Healthcare SA Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) 13.4.5 Helsinn Healthcare SA Recent Development 13.5 Horizon Therapeutics Plc 13.5.1 Horizon Therapeutics Plc Company Details 13.5.2 Horizon Therapeutics Plc Business Overview and Its Total Revenue 13.5.3 Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Introduction 13.5.4 Horizon Therapeutics Plc Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) 13.5.5 Horizon Therapeutics Plc Recent Development 13.6 Kyowa Kirin Co. Ltd. 13.6.1 Kyowa Kirin Co. Ltd. Company Details 13.6.2 Kyowa Kirin Co. Ltd. Business Overview and Its Total Revenue 13.6.3 Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Introduction 13.6.4 Kyowa Kirin Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) 13.6.5 Kyowa Kirin Co. Ltd. Recent Development 13.7 Merck & Co. Inc. 13.7.1 Merck & Co. Inc. Company Details 13.7.2 Merck & Co. Inc. Business Overview and Its Total Revenue 13.7.3 Merck & Co. Inc. Mycosis Fungoides Therapeutics Introduction 13.7.4 Merck & Co. Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) 13.7.5 Merck & Co. Inc. Recent Development 13.8 Seattle Genetics Inc. 13.8.1 Seattle Genetics Inc. Company Details 13.8.2 Seattle Genetics Inc. Business Overview and Its Total Revenue 13.8.3 Seattle Genetics Inc. Mycosis Fungoides Therapeutics Introduction 13.8.4 Seattle Genetics Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) 13.8.5 Seattle Genetics Inc. Recent Development 13.9 Soligenix Inc. 13.9.1 Soligenix Inc. Company Details 13.9.2 Soligenix Inc. Business Overview and Its Total Revenue 13.9.3 Soligenix Inc. Mycosis Fungoides Therapeutics Introduction 13.9.4 Soligenix Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) 13.9.5 Soligenix Inc. Recent Development 13.10 Takeda Pharmaceutical Co. Ltd. 13.10.1 Takeda Pharmaceutical Co. Ltd. Company Details 13.10.2 Takeda Pharmaceutical Co. Ltd. Business Overview and Its Total Revenue 13.10.3 Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Introduction 13.10.4 Takeda Pharmaceutical Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) 13.10.5 Takeda Pharmaceutical Co. Ltd. Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Mycosis Fungoides Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Mycosis Fungoides Therapeutics Revenue Table 3. Ranking of Global Top Mycosis Fungoides Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Small Molecules Table 6. Key Players of Biologics Table 7. Global Mycosis Fungoides Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Mycosis Fungoides Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Mycosis Fungoides Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Mycosis Fungoides Therapeutics Market Share by Regions (2015-2020) Table 11. Global Mycosis Fungoides Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Mycosis Fungoides Therapeutics Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Mycosis Fungoides Therapeutics Market Growth Strategy Table 17. Main Points Interviewed from Key Mycosis Fungoides Therapeutics Players Table 18. Global Mycosis Fungoides Therapeutics Revenue by Players (2015-2020) (Million US$) Table 19. Global Mycosis Fungoides Therapeutics Market Share by Players (2015-2020) Table 20. Global Top Mycosis Fungoides Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mycosis Fungoides Therapeutics as of 2019) Table 21. Global Mycosis Fungoides Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Mycosis Fungoides Therapeutics Product Solution and Service Table 24. Date of Enter into Mycosis Fungoides Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$) Table 27. Global Mycosis Fungoides Therapeutics Market Size Share by Type (2015-2020) Table 28. Global Mycosis Fungoides Therapeutics Revenue Market Share by Type (2021-2026) Table 29. Global Mycosis Fungoides Therapeutics Market Size Share by Application (2015-2020) Table 30. Global Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$) Table 31. Global Mycosis Fungoides Therapeutics Market Size Share by Application (2021-2026) Table 32. North America Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$) Table 33. North America Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020) Table 34. North America Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$) Table 35. North America Mycosis Fungoides Therapeutics Market Share by Type (2015-2020) Table 36. North America Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$) Table 37. North America Mycosis Fungoides Therapeutics Market Share by Application (2015-2020) Table 38. Europe Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020) Table 40. Europe Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$) Table 41. Europe Mycosis Fungoides Therapeutics Market Share by Type (2015-2020) Table 42. Europe Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$) Table 43. Europe Mycosis Fungoides Therapeutics Market Share by Application (2015-2020) Table 44. China Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$) Table 45. China Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020) Table 46. China Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$) Table 47. China Mycosis Fungoides Therapeutics Market Share by Type (2015-2020) Table 48. China Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$) Table 49. China Mycosis Fungoides Therapeutics Market Share by Application (2015-2020) Table 50. Japan Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020) Table 52. Japan Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$) Table 53. Japan Mycosis Fungoides Therapeutics Market Share by Type (2015-2020) Table 54. Japan Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$) Table 55. Japan Mycosis Fungoides Therapeutics Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020) Table 58. Southeast Asia Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Mycosis Fungoides Therapeutics Market Share by Type (2015-2020) Table 60. Southeast Asia Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Mycosis Fungoides Therapeutics Market Share by Application (2015-2020) Table 62. India Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$) Table 63. India Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020) Table 64. India Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$) Table 65. India Mycosis Fungoides Therapeutics Market Share by Type (2015-2020) Table 66. India Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$) Table 67. India Mycosis Fungoides Therapeutics Market Share by Application (2015-2020) Table 68. Central & South America Key Players Mycosis Fungoides Therapeutics Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Mycosis Fungoides Therapeutics Market Share (2019-2020) Table 70. Central & South America Mycosis Fungoides Therapeutics Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Mycosis Fungoides Therapeutics Market Share by Type (2015-2020) Table 72. Central & South America Mycosis Fungoides Therapeutics Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Mycosis Fungoides Therapeutics Market Share by Application (2015-2020) Table 74. Azurity Pharmaceuticals Inc. Company Details Table 75. Azurity Pharmaceuticals Inc. Business Overview Table 76. Azurity Pharmaceuticals Inc. Product Table 77. Azurity Pharmaceuticals Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$) Table 78. Azurity Pharmaceuticals Inc. Recent Development Table 79. Celgene Corp. Company Details Table 80. Celgene Corp. Business Overview Table 81. Celgene Corp. Product Table 82. Celgene Corp. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$) Table 83. Celgene Corp. Recent Development Table 84. Eisai Co. Ltd. Company Details Table 85. Eisai Co. Ltd. Business Overview Table 86. Eisai Co. Ltd. Product Table 87. Eisai Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$) Table 88. Eisai Co. Ltd. Recent Development Table 89. Helsinn Healthcare SA Company Details Table 90. Helsinn Healthcare SA Business Overview Table 91. Helsinn Healthcare SA Product Table 92. Helsinn Healthcare SA Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$) Table 93. Helsinn Healthcare SA Recent Development Table 94. Horizon Therapeutics Plc Company Details Table 95. Horizon Therapeutics Plc Business Overview Table 96. Horizon Therapeutics Plc Product Table 97. Horizon Therapeutics Plc Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$) Table 98. Horizon Therapeutics Plc Recent Development Table 99. Kyowa Kirin Co. Ltd. Company Details Table 100. Kyowa Kirin Co. Ltd. Business Overview Table 101. Kyowa Kirin Co. Ltd. Product Table 102. Kyowa Kirin Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$) Table 103. Kyowa Kirin Co. Ltd. Recent Development Table 104. Merck & Co. Inc. Company Details Table 105. Merck & Co. Inc. Business Overview Table 106. Merck & Co. Inc. Product Table 107. Merck & Co. Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$) Table 108. Merck & Co. Inc. Recent Development Table 109. Seattle Genetics Inc. Business Overview Table 110. Seattle Genetics Inc. Product Table 111. Seattle Genetics Inc. Company Details Table 112. Seattle Genetics Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$) Table 113. Seattle Genetics Inc. Recent Development Table 114. Soligenix Inc. Company Details Table 115. Soligenix Inc. Business Overview Table 116. Soligenix Inc. Product Table 117. Soligenix Inc. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$) Table 118. Soligenix Inc. Recent Development Table 119. Takeda Pharmaceutical Co. Ltd. Company Details Table 120. Takeda Pharmaceutical Co. Ltd. Business Overview Table 121. Takeda Pharmaceutical Co. Ltd. Product Table 122. Takeda Pharmaceutical Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2015-2020) (Million US$) Table 123. Takeda Pharmaceutical Co. Ltd. Recent Development Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Global Mycosis Fungoides Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Small Molecules Features Figure 3. Biologics Features Figure 4. Global Mycosis Fungoides Therapeutics Market Share by Application: 2020 VS 2026 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Other Case Studies Figure 8. Mycosis Fungoides Therapeutics Report Years Considered Figure 9. Global Mycosis Fungoides Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Mycosis Fungoides Therapeutics Market Share by Regions: 2020 VS 2026 Figure 11. Global Mycosis Fungoides Therapeutics Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Mycosis Fungoides Therapeutics Market Share by Players in 2019 Figure 14. Global Top Mycosis Fungoides Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mycosis Fungoides Therapeutics as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Mycosis Fungoides Therapeutics Revenue in 2019 Figure 16. North America Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Mycosis Fungoides Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Azurity Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Azurity Pharmaceuticals Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020) Figure 25. Celgene Corp. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Celgene Corp. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020) Figure 27. Eisai Co. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Eisai Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020) Figure 29. Helsinn Healthcare SA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Helsinn Healthcare SA Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020) Figure 31. Horizon Therapeutics Plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Horizon Therapeutics Plc Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020) Figure 33. Kyowa Kirin Co. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Kyowa Kirin Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020) Figure 35. Merck & Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Merck & Co. Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020) Figure 37. Seattle Genetics Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Seattle Genetics Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020) Figure 39. Soligenix Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Soligenix Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020) Figure 41. Takeda Pharmaceutical Co. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2015-2020) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation Figure 45. Key Executives Interviewed

Azurity Pharmaceuticals Inc. Celgene Corp. Eisai Co. Ltd. Helsinn Healthcare SA Horizon Therapeutics Plc Kyowa Kirin Co. Ltd. Merck & Co. Inc. Seattle Genetics Inc. Soligenix Inc. Takeda Pharmaceutical Co. Ltd.